[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Oncology Drugs Market Report 2017

January 2018 | 106 pages | ID: ABE856CC929EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Oncology Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Oncology Drugs for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Oncology Drugs market competition by top manufacturers/players, with Oncology Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Novartis A.G
  • Laboratrio Cristlia
  • Medley Genomics
  • F. Hoffmann-La Roche Ltd
  • Icon Plc.
  • Sanofi S.A.
  • Laboratoires Pierre Fabre
  • Eurofarma Laboratrios S.A.
  • Ach Laboratrios Farmacuticos S.A.
  • Laboratorios IMA
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • Oral Therapy
  • Injectable Therapy
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Targeted Therapy
  • Chemotherapy
  • Hormonal Therapy
  • Biologic Therapy
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Oncology Drugs Market Report 2017

1 ONCOLOGY DRUGS OVERVIEW

1.1 Product Overview and Scope of Oncology Drugs
1.2 Classification of Oncology Drugs by Product Category
  1.2.1 Asia-Pacific Oncology Drugs Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Oncology Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Oral Therapy
  1.2.4 Injectable Therapy
1.3 Asia-Pacific Oncology Drugs Market by Application/End Users
  1.3.1 Asia-Pacific Oncology Drugs Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Targeted Therapy
  1.3.3 Chemotherapy
  1.3.4 Hormonal Therapy
  1.3.5 Biologic Therapy
1.4 Asia-Pacific Oncology Drugs Market by Region
  1.4.1 Asia-Pacific Oncology Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Oncology Drugs (2012-2022)
  1.5.1 Asia-Pacific Oncology Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Oncology Drugs Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC ONCOLOGY DRUGS COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Oncology Drugs Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Oncology Drugs Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Oncology Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Oncology Drugs (Volume and Value) by Type
  2.2.1 Asia-Pacific Oncology Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Oncology Drugs Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Oncology Drugs (Volume) by Application
2.4 Asia-Pacific Oncology Drugs (Volume and Value) by Region
  2.4.1 Asia-Pacific Oncology Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Oncology Drugs Revenue and Market Share by Region (2012-2017)

3 CHINA ONCOLOGY DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 China Oncology Drugs Sales and Value (2012-2017)
  3.1.1 China Oncology Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Oncology Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 China Oncology Drugs Sales Price Trend (2012-2017)
3.2 China Oncology Drugs Sales Volume and Market Share by Type
3.3 China Oncology Drugs Sales Volume and Market Share by Application

4 JAPAN ONCOLOGY DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Oncology Drugs Sales and Value (2012-2017)
  4.1.1 Japan Oncology Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Oncology Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Oncology Drugs Sales Price Trend (2012-2017)
4.2 Japan Oncology Drugs Sales Volume and Market Share by Type
4.3 Japan Oncology Drugs Sales Volume and Market Share by Application

5 SOUTH KOREA ONCOLOGY DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Oncology Drugs Sales and Value (2012-2017)
  5.1.1 South Korea Oncology Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Oncology Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Oncology Drugs Sales Price Trend (2012-2017)
5.2 South Korea Oncology Drugs Sales Volume and Market Share by Type
5.3 South Korea Oncology Drugs Sales Volume and Market Share by Application

6 TAIWAN ONCOLOGY DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Oncology Drugs Sales and Value (2012-2017)
  6.1.1 Taiwan Oncology Drugs Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Oncology Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Oncology Drugs Sales Price Trend (2012-2017)
6.2 Taiwan Oncology Drugs Sales Volume and Market Share by Type
6.3 Taiwan Oncology Drugs Sales Volume and Market Share by Application

7 INDIA ONCOLOGY DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 India Oncology Drugs Sales and Value (2012-2017)
  7.1.1 India Oncology Drugs Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Oncology Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 India Oncology Drugs Sales Price Trend (2012-2017)
7.2 India Oncology Drugs Sales Volume and Market Share by Type
7.3 India Oncology Drugs Sales Volume and Market Share by Application

8 SOUTHEAST ASIA ONCOLOGY DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Oncology Drugs Sales and Value (2012-2017)
  8.1.1 Southeast Asia Oncology Drugs Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Oncology Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Oncology Drugs Sales Price Trend (2012-2017)
8.2 Southeast Asia Oncology Drugs Sales Volume and Market Share by Type
8.3 Southeast Asia Oncology Drugs Sales Volume and Market Share by Application

9 AUSTRALIA ONCOLOGY DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Oncology Drugs Sales and Value (2012-2017)
  9.1.1 Australia Oncology Drugs Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Oncology Drugs Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Oncology Drugs Sales Price Trend (2012-2017)
9.2 Australia Oncology Drugs Sales Volume and Market Share by Type
9.3 Australia Oncology Drugs Sales Volume and Market Share by Application

10 ASIA-PACIFIC ONCOLOGY DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Novartis A.G
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Oncology Drugs Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Novartis A.G Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Laboratrio Cristlia
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Oncology Drugs Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Laboratrio Cristlia Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Medley Genomics
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Oncology Drugs Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Medley Genomics Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 F. Hoffmann-La Roche Ltd
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Oncology Drugs Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 F. Hoffmann-La Roche Ltd Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Icon Plc.
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Oncology Drugs Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Icon Plc. Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Sanofi S.A.
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Oncology Drugs Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Sanofi S.A. Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Laboratoires Pierre Fabre
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Oncology Drugs Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Laboratoires Pierre Fabre Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Eurofarma Laboratrios S.A.
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Oncology Drugs Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Eurofarma Laboratrios S.A. Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Ach Laboratrios Farmacuticos S.A.
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Oncology Drugs Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Ach Laboratrios Farmacuticos S.A. Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Laboratorios IMA
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Oncology Drugs Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Laboratorios IMA Oncology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview

11 ONCOLOGY DRUGS MANUFACTURING COST ANALYSIS

11.1 Oncology Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Oncology Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Oncology Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Oncology Drugs Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC ONCOLOGY DRUGS MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Oncology Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Oncology Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Oncology Drugs Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Oncology Drugs Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Oncology Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Oncology Drugs Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Oncology Drugs Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Oncology Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Oncology Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Oncology Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Oncology Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Oncology Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Oncology Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Oncology Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Oncology Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Oncology Drugs Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Oncology Drugs Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Oncology Drugs Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Oncology Drugs Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Oncology Drugs
Figure Asia-Pacific Oncology Drugs Sales Volume (MT) by Type (2012-2022)
Figure Asia-Pacific Oncology Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Oral Therapy Product Picture
Figure Injectable Therapy Product Picture
Figure Asia-Pacific Oncology Drugs Sales (MT) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Oncology Drugs by Application in 2016
Figure Targeted Therapy Examples
Table Key Downstream Customer in Targeted Therapy
Figure Chemotherapy Examples
Table Key Downstream Customer in Chemotherapy
Figure Hormonal Therapy Examples
Table Key Downstream Customer in Hormonal Therapy
Figure Biologic Therapy Examples
Table Key Downstream Customer in Biologic Therapy
Figure Asia-Pacific Oncology Drugs Market Size (Million USD) by Region (2012-2022)
Figure China Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Oncology Drugs Sales Volume (MT) and Growth Rate (2012-2022)
Figure Asia-Pacific Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Oncology Drugs Market Major Players Product Sales Volume (MT)(2012-2017)
Table Asia-Pacific Oncology Drugs Sales (MT) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Oncology Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Oncology Drugs Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Oncology Drugs Sales Share by Players/Suppliers
Figure Asia-Pacific Oncology Drugs Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Oncology Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Oncology Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Oncology Drugs Revenue Share by Players
Figure 2017 Asia-Pacific Oncology Drugs Revenue Share by Players
Table Asia-Pacific Oncology Drugs Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Oncology Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Oncology Drugs by Type (2012-2017)
Figure Asia-Pacific Oncology Drugs Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Oncology Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Oncology Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oncology Drugs by Type (2012-2017)
Figure Asia-Pacific Oncology Drugs Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Oncology Drugs Sales Volume (MT) and Market Share by Region (2012-2017)
Table Asia-Pacific Oncology Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Oncology Drugs by Region (2012-2017)
Figure Asia-Pacific Oncology Drugs Sales Market Share by Region in 2016
Table Asia-Pacific Oncology Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Oncology Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Oncology Drugs by Region (2012-2017)
Figure Asia-Pacific Oncology Drugs Revenue Market Share by Region in 2016
Table Asia-Pacific Oncology Drugs Sales Volume (MT) and Market Share by Application (2012-2017)
Table Asia-Pacific Oncology Drugs Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Oncology Drugs Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Oncology Drugs Sales Market Share by Application (2012-2017)
Figure China Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure China Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Oncology Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table China Oncology Drugs Sales Volume (MT) by Type (2012-2017)
Table China Oncology Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Oncology Drugs Sales Volume Market Share by Type in 2016
Table China Oncology Drugs Sales Volume (MT) by Applications (2012-2017)
Table China Oncology Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Oncology Drugs Sales Volume Market Share by Application in 2016
Figure Japan Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Japan Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Oncology Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table Japan Oncology Drugs Sales Volume (MT) by Type (2012-2017)
Table Japan Oncology Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Oncology Drugs Sales Volume Market Share by Type in 2016
Table Japan Oncology Drugs Sales Volume (MT) by Applications (2012-2017)
Table Japan Oncology Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Oncology Drugs Sales Volume Market Share by Application in 2016
Figure South Korea Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure South Korea Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Oncology Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table South Korea Oncology Drugs Sales Volume (MT) by Type (2012-2017)
Table South Korea Oncology Drugs Sales Volume Market Share by Type (2012-2017)
Figure South Korea Oncology Drugs Sales Volume Market Share by Type in 2016
Table South Korea Oncology Drugs Sales Volume (MT) by Applications (2012-2017)
Table South Korea Oncology Drugs Sales Volume Market Share by Application (2012-2017)
Figure South Korea Oncology Drugs Sales Volume Market Share by Application in 2016
Figure Taiwan Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Taiwan Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Oncology Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table Taiwan Oncology Drugs Sales Volume (MT) by Type (2012-2017)
Table Taiwan Oncology Drugs Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Oncology Drugs Sales Volume Market Share by Type in 2016
Table Taiwan Oncology Drugs Sales Volume (MT) by Applications (2012-2017)
Table Taiwan Oncology Drugs Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Oncology Drugs Sales Volume Market Share by Application in 2016
Figure India Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure India Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Oncology Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table India Oncology Drugs Sales Volume (MT) by Type (2012-2017)
Table India Oncology Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Oncology Drugs Sales Volume Market Share by Type in 2016
Table India Oncology Drugs Sales Volume (MT) by Application (2012-2017)
Table India Oncology Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Oncology Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Southeast Asia Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Oncology Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table Southeast Asia Oncology Drugs Sales Volume (MT) by Type (2012-2017)
Table Southeast Asia Oncology Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Oncology Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Oncology Drugs Sales Volume (MT) by Applications (2012-2017)
Table Southeast Asia Oncology Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Oncology Drugs Sales Volume Market Share by Application in 2016
Figure Australia Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Australia Oncology Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Oncology Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table Australia Oncology Drugs Sales Volume (MT) by Type (2012-2017)
Table Australia Oncology Drugs Sales Volume Market Share by Type (2012-2017)
Figure Australia Oncology Drugs Sales Volume Market Share by Type in 2016
Table Australia Oncology Drugs Sales Volume (MT) by Applications (2012-2017)
Table Australia Oncology Drugs Sales Volume Market Share by Application (2012-2017)
Figure Australia Oncology Drugs Sales Volume Market Share by Application in 2016
Table Novartis A.G Oncology Drugs Basic Information List
Table Novartis A.G Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis A.G Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Novartis A.G Oncology Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Novartis A.G Oncology Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Laboratrio Cristlia Oncology Drugs Basic Information List
Table Laboratrio Cristlia Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Laboratrio Cristlia Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Laboratrio Cristlia Oncology Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Laboratrio Cristlia Oncology Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Medley Genomics Oncology Drugs Basic Information List
Table Medley Genomics Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Medley Genomics Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Medley Genomics Oncology Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Medley Genomics Oncology Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table F. Hoffmann-La Roche Ltd Oncology Drugs Basic Information List
Table F. Hoffmann-La Roche Ltd Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd Oncology Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure F. Hoffmann-La Roche Ltd Oncology Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Icon Plc. Oncology Drugs Basic Information List
Table Icon Plc. Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Icon Plc. Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Icon Plc. Oncology Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Icon Plc. Oncology Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Sanofi S.A. Oncology Drugs Basic Information List
Table Sanofi S.A. Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi S.A. Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Sanofi S.A. Oncology Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Sanofi S.A. Oncology Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Laboratoires Pierre Fabre Oncology Drugs Basic Information List
Table Laboratoires Pierre Fabre Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Laboratoires Pierre Fabre Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Laboratoires Pierre Fabre Oncology Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Laboratoires Pierre Fabre Oncology Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Eurofarma Laboratrios S.A. Oncology Drugs Basic Information List
Table Eurofarma Laboratrios S.A. Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Eurofarma Laboratrios S.A. Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Eurofarma Laboratrios S.A. Oncology Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Eurofarma Laboratrios S.A. Oncology Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Ach Laboratrios Farmacuticos S.A. Oncology Drugs Basic Information List
Table Ach Laboratrios Farmacuticos S.A. Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Ach Laboratrios Farmacuticos S.A. Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Ach Laboratrios Farmacuticos S.A. Oncology Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Ach Laboratrios Farmacuticos S.A. Oncology Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Laboratorios IMA Oncology Drugs Basic Information List
Table Laboratorios IMA Oncology Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Laboratorios IMA Oncology Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Laboratorios IMA Oncology Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Laboratorios IMA Oncology Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Kg) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Drugs
Figure Manufacturing Process Analysis of Oncology Drugs
Figure Oncology Drugs Industrial Chain Analysis
Table Raw Materials Sources of Oncology Drugs Major Manufacturers in 2016
Table Major Buyers of Oncology Drugs
Table Distributors/Traders List
Figure Asia-Pacific Oncology Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Oncology Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Oncology Drugs Price (USD/Kg) and Trend Forecast (2017-2022)
Table Asia-Pacific Oncology Drugs Sales Volume (MT) Forecast by Region (2017-2022)
Figure Asia-Pacific Oncology Drugs Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Oncology Drugs Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Oncology Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Oncology Drugs Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Oncology Drugs Revenue Market Share Forecast by Region in 2022
Figure China Oncology Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure China Oncology Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Oncology Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Japan Oncology Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Oncology Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure South Korea Oncology Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Oncology Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Taiwan Oncology Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Oncology Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure India Oncology Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Oncology Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Oncology Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Oncology Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Australia Oncology Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Oncology Drugs Sales (MT) Forecast by Type (2017-2022)
Figure Asia-Pacific Oncology Drugs Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Oncology Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Oncology Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Oncology Drugs Price (USD/Kg) Forecast by Type (2017-2022)
Table Asia-Pacific Oncology Drugs Sales (MT) Forecast by Application (2017-2022)
Figure Asia-Pacific Oncology Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories